| License: Creative Commons Attribution 4.0 PDF - Published Version (636kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-415477
- DOI to cite this document:
- 10.5283/epub.41547
Abstract
Differentiated thyroid cancer (DTC) is a rare malignant disease, although its incidence has increased over the last few decades. It derives from follicular thyroid cells. Generally speaking, the prognosis is excellent. If treatment according to the current guidelines is given, cases of recurrence or persistence are rare. DTC requires special expertise by the treating physician. In recent years, ...
Owner only: item control page